- COVID-19 vaccine maker Novavax, on Friday, erased doubts about its ability to remain in business by removing a so-called"going concern" notice.
In February, Novavax had raised doubts about its ability to remain in business and announced plans to slash spending as it worked to prepare for a fall vaccination campaign.The company also said on Friday that its revenue rose to $94 million in the first quarter, from $81 million in the same period in 2023.It has been our privilege to have the trust and support of our East Coast communities for the last 200 years. Our SaltWire team is always watching out for the place we call home.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: